Elena Robbi
Research Subjects
Elena Robbi has a total of 46 co-authors. Here are the top co-authors by number of shared publications:
- Gian Domenico Pinna
Laboratory for the Study of Ventilatory Instability, Department of Biomedical Engineering, Montescano Institute - IRCCS, Istituti Clinici Scientifici Maugeri, Montescano, Italy
26 shared publications - Roberto Maestri
Department of Biomedical Engineering, Montescano Institute, Istituti Clinici Scientifici Maugeri IRCCS, 27040 Montescano, Italy
26 shared publications Maria Teresa La Rovere
Department of Cardiology, Istituti Clinici Scientifici Maugeri IRCCS, Pavia, Italy
13 shared publications- Anna Eugenia Taurino
Respiratory Function and Sleep Unit, Istituti Clinici Scientifici Maugeri, IRCCS Montescano, Montescano, Pavia, Italy
5 shared publications M.T. La Rovere
Department of Cardiology, S Maugeri Foundation, IRCCS, Montescano, Italy
5 shared publicationsAngelo Caporotondi
Department of Cardiology, Istituti Clinici Scientifici Maugeri, IRCCS, Montescano, (PV), Italy
4 shared publications
Latest Publications
- 21 October 2026
- Published by Elsevier in Sleep Medicine
- Vol. 149
Bridging the gap: Are OSA patients ready for Telemedicine? An Italian perspective
- 21 October 2026
- Published by Elsevier in Sleep Medicine
- Vol. 149
Bridging the gap: Are OSA patients ready for Telemedicine? An Italian perspective
- 1 March 2019
- Published by Elsevier in Sleep Medicine
- Vol. 55, 6-13
Arterial oxygen saturation during Cheyne-Stokes respiration in heart failure patients: does measurement site matter?
- 1 March 2019
- Published by Elsevier in Sleep Medicine
- Vol. 55, 6-13
Arterial oxygen saturation during Cheyne-Stokes respiration in heart failure patients: does measurement site matter?
- 1 September 2018
- Published by Elsevier in Clinical Neurophysiology
- Vol. 129 (9) , 1955-1963
Temporal relationship between arousals and Cheyne-Stokes respiration with central sleep apnea in heart failure patients
- 1 September 2018
- Published by Elsevier in Clinical Neurophysiology
- Vol. 129 (9) , 1955-1963
Temporal relationship between arousals and Cheyne-Stokes respiration with central sleep apnea in heart failure patients
- 12 October 2017
- Published by Oxford University Press (OUP) in European Journal of Heart Failure
- Vol. 20 (5) , 934-936
Daytime Periodic Breathing During Short-Term Laboratory Recordings in Heart Failure Patients: The Iceberg Tip of Central Sleep Apnoea?
- 12 October 2017
- Published by Oxford University Press (OUP) in European Journal of Heart Failure
- Vol. 20 (5) , 934-936
Daytime Periodic Breathing During Short-Term Laboratory Recordings in Heart Failure Patients: The Iceberg Tip of Central Sleep Apnoea?
- 14 October 2015
- Published by Oxford University Press (OUP) in European Journal of Heart Failure
- Vol. 17 (12) , 1302-1309
Differential Impact of Body Position on the Severity of Disordered Breathing in Heart Failure Patients with Obstructive vs. Central Sleep Apnoea
Aims Obstructive (OSA) and central sleep apnoea (CSA) are a common comorbidity in patients with heart failure. The purpose of this study was to assess and compare the impact of body position on the severity of sleep apnoea in these two groups of patients. Methods and results Standard polysomnography was performed in consecutive, clinically stable, optimally treated patients with moderate-to-severe heart failure and systolic dysfunction. Patients with an apnoea–hypopnoea index (AHI) ≥15/h (n = 120) were included in the study. The severity of sleep-disordered breathing was quantified by the AHI, the mean value of oxygen desaturations (O2desat) and the apnoea ratio. Data from the right and left positions were combined into a single lateral position. Positional sleep apnoea was defined as a >50% reduction in the AHI between the supine and the lateral position. Twenty-nine and 91 subjects had dominant OSA and CSA, respectively. The AHI markedly decreased from the supine to the lateral position in both groups [OSA: (median [q1,q3]) 50.3 [36.9, 67.6]/h vs. 10.4 [7.0, 18.5]/h, P < 0.0001; CSA: 47.4 [37.6, 56.0]/h vs. 19.3 [11.9, 33.3]/h]. The reduction was greater in OSA patients (p = 0.027). Similarly, O2desat and the apnoea ratio decreased in the lateral position (P < 0.0001). Positional sleep apnoea was observed in 76% of OSA and 53% of CSA patients (P = 0.028). Conclusion This study demonstrates that the lateral sleeping position has a major beneficial effect on the severity of sleep-disordered breathing in heart failure patients, and that this improvement is greater in subjects with OSA than in those with CSA.
- 14 October 2015
- Published by Oxford University Press (OUP) in European Journal of Heart Failure
- Vol. 17 (12) , 1302-1309
Differential Impact of Body Position on the Severity of Disordered Breathing in Heart Failure Patients with Obstructive vs. Central Sleep Apnoea
Aims Obstructive (OSA) and central sleep apnoea (CSA) are a common comorbidity in patients with heart failure. The purpose of this study was to assess and compare the impact of body position on the severity of sleep apnoea in these two groups of patients. Methods and results Standard polysomnography was performed in consecutive, clinically stable, optimally treated patients with moderate-to-severe heart failure and systolic dysfunction. Patients with an apnoea–hypopnoea index (AHI) ≥15/h (n = 120) were included in the study. The severity of sleep-disordered breathing was quantified by the AHI, the mean value of oxygen desaturations (O2desat) and the apnoea ratio. Data from the right and left positions were combined into a single lateral position. Positional sleep apnoea was defined as a >50% reduction in the AHI between the supine and the lateral position. Twenty-nine and 91 subjects had dominant OSA and CSA, respectively. The AHI markedly decreased from the supine to the lateral position in both groups [OSA: (median [q1,q3]) 50.3 [36.9, 67.6]/h vs. 10.4 [7.0, 18.5]/h, P < 0.0001; CSA: 47.4 [37.6, 56.0]/h vs. 19.3 [11.9, 33.3]/h]. The reduction was greater in OSA patients (p = 0.027). Similarly, O2desat and the apnoea ratio decreased in the lateral position (P < 0.0001). Positional sleep apnoea was observed in 76% of OSA and 53% of CSA patients (P = 0.028). Conclusion This study demonstrates that the lateral sleeping position has a major beneficial effect on the severity of sleep-disordered breathing in heart failure patients, and that this improvement is greater in subjects with OSA than in those with CSA.
- 29 November 2013
- Published by Wiley in Journal of Sleep Research
- Vol. 23 (3) , 349-359
Sleep-wake fluctuations and respiratory events during Cheyne-Stokes respiration in patients with heart failure
- 29 November 2013
- Published by Wiley in Journal of Sleep Research
- Vol. 23 (3) , 349-359
Sleep-wake fluctuations and respiratory events during Cheyne-Stokes respiration in patients with heart failure
- 17 November 2013
- Published by Springer Nature in Sleep and Breathing
- Vol. 18 (3) , 475-482
Can cardiorespiratory polygraphy replace portable polysomnography in the assessment of sleep-disordered breathing in heart failure patients?
Portable polysomnography (PSG) and cardiorespiratory polygraphy are increasingly being used in the assessment of sleep-disordered breathing (SDB) in heart failure patients. Scoring of SDB from cardiorespiratory polygraphy recordings is based only on respiratory signals, while electroencephalographic, electrooculographic and electromyographic channels are taken into account when using PSG recordings. The aim of this study was to assess the agreement between these two scoring methods. An overnight sleep study was performed in 67 heart failure patients using a standard portable polysomnograph. Each recording was scored twice, once using all acquired signals (PSG mode) and, after a median of 64 days, using only respiratory signals (cardiorespiratory mode). Agreement was assessed by Bland–Altman analysis and Cohen’s kappa. We found that (1) more respiratory events were detected using cardiorespiratory analysis [median (25th percentile, 75th percentile), 75 (39, 200) events] compared to analysis of portable PSG [69 (29, 173) events, p < 0.0001], the extra events being, for the vast majority, central in origin; (2) the apnea/hypopnea index (AHI) estimated by cardiorespiratory polygraphy [11.9 (5.7, 30.8)/h] showed a negligible negative bias relative to portable PSG [15.1 (5.7, 33.6)/h; bias, −0.8 (−2.9, 0.4)/h, p = 0.0002]; (3) limits of agreement between the two systems (−6.2/h, 1.7/h) were much smaller than those previously observed between two nights using the same scoring modality; and (4) the kappa coefficient using categorised AHI was 0.89 (95 % confidence interval (CI) 0.82, 0.96). We found a high degree of agreement between the AHIs obtained from the two scoring methods, thus suggesting that cardiorespiratory polygraphy may be used as an alternative to portable PSG in the assessment of SDB in heart failure patients.
- 17 November 2013
- Published by Springer Nature in Sleep and Breathing
- Vol. 18 (3) , 475-482
Can cardiorespiratory polygraphy replace portable polysomnography in the assessment of sleep-disordered breathing in heart failure patients?
Portable polysomnography (PSG) and cardiorespiratory polygraphy are increasingly being used in the assessment of sleep-disordered breathing (SDB) in heart failure patients. Scoring of SDB from cardiorespiratory polygraphy recordings is based only on respiratory signals, while electroencephalographic, electrooculographic and electromyographic channels are taken into account when using PSG recordings. The aim of this study was to assess the agreement between these two scoring methods. An overnight sleep study was performed in 67 heart failure patients using a standard portable polysomnograph. Each recording was scored twice, once using all acquired signals (PSG mode) and, after a median of 64 days, using only respiratory signals (cardiorespiratory mode). Agreement was assessed by Bland–Altman analysis and Cohen’s kappa. We found that (1) more respiratory events were detected using cardiorespiratory analysis [median (25th percentile, 75th percentile), 75 (39, 200) events] compared to analysis of portable PSG [69 (29, 173) events, p < 0.0001], the extra events being, for the vast majority, central in origin; (2) the apnea/hypopnea index (AHI) estimated by cardiorespiratory polygraphy [11.9 (5.7, 30.8)/h] showed a negligible negative bias relative to portable PSG [15.1 (5.7, 33.6)/h; bias, −0.8 (−2.9, 0.4)/h, p = 0.0002]; (3) limits of agreement between the two systems (−6.2/h, 1.7/h) were much smaller than those previously observed between two nights using the same scoring modality; and (4) the kappa coefficient using categorised AHI was 0.89 (95 % confidence interval (CI) 0.82, 0.96). We found a high degree of agreement between the AHIs obtained from the two scoring methods, thus suggesting that cardiorespiratory polygraphy may be used as an alternative to portable PSG in the assessment of SDB in heart failure patients.
- 1 October 2011
- Published by Wiley in Journal of Sleep Research
- Vol. 21 (3) , 342-351
A hybrid approach for continuous detection of sleep‐wakefulness fluctuations: validation in patients with Cheyne–Stokes respiration
Fluctuations in sleep/wake state have been proposed as an important mechanism contributing to the development of oscillatory breathing patterns, including Cheyne–Stokes respiration in patients with heart failure. In order to properly assess the interactions between changes in state and changes in ventilatory parameters, a methodology capable of continuously and reliably detecting state transitions is needed. Traditional fixed‐epoch analysis of polysomnographic recordings is not suitable for this purpose. Moreover, visual identification of changes in the dominant electroencephalogram activity at the transition from wakefulness to sleep and vice versa is often very subjective. We have therefore developed a hybrid approach – including both visual scoring and computer‐based procedures – for continuous analysis of state transitions from polysomnographic recordings, specifically tailored for fluctuations between wakefulness and non‐rapid eye movement‐1 and ‐2 sleep. The overall analysis process comprises three major phases: (1) manual identification of relevant electroencephalogram/electrooculogram features and events, including a sample of unequivocal alpha and theta‐delta activity; (2) automatic statistical discrimination of dominant electroencephalogram activity; and (3) state classification (wakefulness, non‐rapid eye movement‐1 and ‐2). The latter is carried out by merging information from visual scoring with the output of the discriminator. Validation has been carried out in 16 patients with heart failure during daytime Cheyne–Stokes respiration, using a training and testing set of electroencephalogram polysomnograms. The statistical discriminator correctly classified 99.1 ± 1.4% and 99.2 ± 1.1% of unequivocal alpha and theta‐delta activity. This approach has therefore the potential to be used to reliably measure the incidence and location of sleep–wake transitions during abnormal breathing patterns, as well as their temporal relationship with major ventilatory events.
- 1 October 2011
- Published by Wiley in Journal of Sleep Research
- Vol. 21 (3) , 342-351
A hybrid approach for continuous detection of sleep‐wakefulness fluctuations: validation in patients with Cheyne–Stokes respiration
Fluctuations in sleep/wake state have been proposed as an important mechanism contributing to the development of oscillatory breathing patterns, including Cheyne–Stokes respiration in patients with heart failure. In order to properly assess the interactions between changes in state and changes in ventilatory parameters, a methodology capable of continuously and reliably detecting state transitions is needed. Traditional fixed‐epoch analysis of polysomnographic recordings is not suitable for this purpose. Moreover, visual identification of changes in the dominant electroencephalogram activity at the transition from wakefulness to sleep and vice versa is often very subjective. We have therefore developed a hybrid approach – including both visual scoring and computer‐based procedures – for continuous analysis of state transitions from polysomnographic recordings, specifically tailored for fluctuations between wakefulness and non‐rapid eye movement‐1 and ‐2 sleep. The overall analysis process comprises three major phases: (1) manual identification of relevant electroencephalogram/electrooculogram features and events, including a sample of unequivocal alpha and theta‐delta activity; (2) automatic statistical discrimination of dominant electroencephalogram activity; and (3) state classification (wakefulness, non‐rapid eye movement‐1 and ‐2). The latter is carried out by merging information from visual scoring with the output of the discriminator. Validation has been carried out in 16 patients with heart failure during daytime Cheyne–Stokes respiration, using a training and testing set of electroencephalogram polysomnograms. The statistical discriminator correctly classified 99.1 ± 1.4% and 99.2 ± 1.1% of unequivocal alpha and theta‐delta activity. This approach has therefore the potential to be used to reliably measure the incidence and location of sleep–wake transitions during abnormal breathing patterns, as well as their temporal relationship with major ventilatory events.
- 1 August 2011
- Published by Wolters Kluwer Health in Journal Of Hypertension
- Vol. 29 (8) , 1546-1552
Comparison of the prognostic values of invasive and noninvasive assessments of baroreflex sensitivity in heart failure
No studies have compared the prognostic values of invasive (phenylephrine, Phe) and noninvasive (transfer function) assessments of baroreflex sensitivity (BRS). Three hundred and one heart failure patients [age: 53 ± 8 years, New York Heart Association class II-III: 88%, left-ventricular ejection fraction (LVEF): 28 ± 8%] underwent an 8 min ECG and arterial pressure recording, followed by Phe administration. Phe-BRS and transfer function BRS (TF-BRS) could be measured in 89 and 72% of cases, respectively. The correlation and the 5-95th percentiles of the difference between the two methods were 0.61 (P < 0.0001), and -7.6, +7.5 ms/mmHg, respectively. During a median of 36 months, 23% of the patients experienced a cardiac event. In the common dataset of 202 patients, both BRS measurements (<3 ms/mmHg) were significantly associated with the outcome (both P < 0.001), but Phe-BRS had a better discriminatory power (area under the curve (AUC): 0.74 vs. 0.66, P = 0.03). Patients with a missing BRS (due to high grade ectopic activity) had a higher event rate (Phe-BRS: 38 vs. 24%, P = 0.23; TF-BRS: 37 vs. 19%, P = 0.002). Using this information, a prognostic index was derived for each BRS method, increasing measurability to 94 and 98%, respectively. Both indexes significantly predicted the outcome after adjustment for clinical covariates [hazard ratio (95% CI): 1.9 (1.1-3.3), P = 0.03 for Phe index and 2.0 (1.1-3.7), P = 0.02 for transfer function index]. Although the measurability of TF-BRS in heart failure patients is impaired, prognostic information can be extended to almost all patients, with a predictive power similar to that of Phe-BRS. The two measurements, however, convey a certain amount of independent prognostic information. Hence, TF-BRS can be integrated with but not replace Phe-BRS.
- 1 August 2011
- Published by Wolters Kluwer Health in Journal Of Hypertension
- Vol. 29 (8) , 1546-1552
Comparison of the prognostic values of invasive and noninvasive assessments of baroreflex sensitivity in heart failure
No studies have compared the prognostic values of invasive (phenylephrine, Phe) and noninvasive (transfer function) assessments of baroreflex sensitivity (BRS). Three hundred and one heart failure patients [age: 53 ± 8 years, New York Heart Association class II-III: 88%, left-ventricular ejection fraction (LVEF): 28 ± 8%] underwent an 8 min ECG and arterial pressure recording, followed by Phe administration. Phe-BRS and transfer function BRS (TF-BRS) could be measured in 89 and 72% of cases, respectively. The correlation and the 5-95th percentiles of the difference between the two methods were 0.61 (P < 0.0001), and -7.6, +7.5 ms/mmHg, respectively. During a median of 36 months, 23% of the patients experienced a cardiac event. In the common dataset of 202 patients, both BRS measurements (<3 ms/mmHg) were significantly associated with the outcome (both P < 0.001), but Phe-BRS had a better discriminatory power (area under the curve (AUC): 0.74 vs. 0.66, P = 0.03). Patients with a missing BRS (due to high grade ectopic activity) had a higher event rate (Phe-BRS: 38 vs. 24%, P = 0.23; TF-BRS: 37 vs. 19%, P = 0.002). Using this information, a prognostic index was derived for each BRS method, increasing measurability to 94 and 98%, respectively. Both indexes significantly predicted the outcome after adjustment for clinical covariates [hazard ratio (95% CI): 1.9 (1.1-3.3), P = 0.03 for Phe index and 2.0 (1.1-3.7), P = 0.02 for transfer function index]. Although the measurability of TF-BRS in heart failure patients is impaired, prognostic information can be extended to almost all patients, with a predictive power similar to that of Phe-BRS. The two measurements, however, convey a certain amount of independent prognostic information. Hence, TF-BRS can be integrated with but not replace Phe-BRS.